Clinical Research in the Middle East & Africa: A Conversation with Alaa Assem from CTI
Update: 2025-07-14
Description
Alaa Assem, Managing Director for CTI in the Europe & MEA regions, joins us to discuss the evolution of clinical trials in the Middle East and Africa. With over a decade of experience in pharma and CROs, Alaa shares how CTI has built a strong regional presence, the impact of COVID-19, and why sponsors should consider the region for future trials.
Topics Covered:
- CTI’s history and expansion in the Middle East & Africa
- Local expertise and regulatory evolution
- Vaccine research and biotech investment
- Gene therapy, AI, and the future of clinical trials
Timestamps:
- 00:00 – Meet Alaa and his background
- 00:56 – CTI’s regional roots and growth
- 02:19 – Why local presence matters
- 03:20 – Clinical research evolution in the region
- 05:02 – COVID-19’s transformative impact
- 06:44 – Vaccine research and biotech hubs
- 08:33 – Advice for sponsors entering the region
- 10:33 – Changing perceptions and realities
- 12:52 – CTI’s readiness and expansion strategy
- 14:06 – Future growth and innovation
- 15:42 – Alaa’s excitement for the future of research
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
